These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 27636408)
1. Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma. Kutsenko A; Ladenheim MR; Kim N; Nguyen P; Chen V; Jayasekera C; Yang JD; Kumari R; Roberts L; Nguyen MH J Clin Gastroenterol; 2017 Apr; 51(4):384-390. PubMed ID: 27636408 [TBL] [Abstract][Full Text] [Related]
2. Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA. Tong MJ; Chavalitdhamrong D; Lu DS; Raman SS; Gomes A; Duffy JP; Hong JC; Busuttil RW J Clin Gastroenterol; 2010 Mar; 44(3):e63-70. PubMed ID: 19745756 [TBL] [Abstract][Full Text] [Related]
3. Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma. Yip B; Wantuck JM; Kim LH; Wong RJ; Ahmed A; Garcia G; Nguyen MH Dig Dis Sci; 2014 Jan; 59(1):192-200. PubMed ID: 24282055 [TBL] [Abstract][Full Text] [Related]
4. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012. Stewart SL; Kwong SL; Bowlus CL; Nguyen TT; Maxwell AE; Bastani R; Chak EW; Chen MS World J Gastroenterol; 2016 Oct; 22(38):8584-8595. PubMed ID: 27784971 [TBL] [Abstract][Full Text] [Related]
5. Disparities in hepatocellular carcinoma survival among Californians of Asian ancestry, 1988 to 2007. Kwong SL; Stewart SL; Aoki CA; Chen MS Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2747-57. PubMed ID: 20823106 [TBL] [Abstract][Full Text] [Related]
6. Patterns and co-occurrence of risk factors for hepatocellular carcinoma in four Asian American communities: a cross-sectional study. Stewart SL; Dang JH; Török NJ; Chen MS BMJ Open; 2019 Jun; 9(6):e026409. PubMed ID: 31256022 [TBL] [Abstract][Full Text] [Related]
7. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma. Jun TW; Yeh ML; Yang JD; Chen VL; Nguyen P; Giama NH; Huang CF; Hsing AW; Dai CY; Huang JF; Chuang WL; Roberts LR; Yu ML; Nguyen MH Liver Int; 2018 May; 38(5):895-902. PubMed ID: 29045023 [TBL] [Abstract][Full Text] [Related]
8. Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-Americans. Wong PY; Xia V; Imagawa DK; Hoefs J; Hu KQ J Immigr Minor Health; 2011 Oct; 13(5):842-8. PubMed ID: 20890660 [TBL] [Abstract][Full Text] [Related]
9. [Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma]. Rim MY; Kwon OS; Ha M; Kim JS; Ko KI; Kim DK; Jang PK; Han JY; Park PH; Jung YK; Choi DJ; Kim YS; Kim JH Korean J Gastroenterol; 2014 May; 63(5):292-8. PubMed ID: 24870301 [TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program. Pollack HJ; Kwon SC; Wang SH; Wyatt LC; Trinh-Shevrin C; Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2229-39. PubMed ID: 25368398 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population. Kogiso T; Sagawa T; Kodama K; Taniai M; Hashimoto E; Tokushige K J Gastroenterol Hepatol; 2020 Sep; 35(9):1579-1589. PubMed ID: 31975453 [TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis. Bengtsson B; Stål P; Wahlin S; Björkström NK; Hagström H Liver Int; 2019 Jun; 39(6):1098-1108. PubMed ID: 30829446 [TBL] [Abstract][Full Text] [Related]
13. Effect of ethnicity on liver transplant for hepatocellular carcinoma. Couto CA; Gelape CL; Calmet F; Martin P; Levy C Exp Clin Transplant; 2013 Aug; 11(4):339-45. PubMed ID: 23905912 [TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants. Pais R; Lebray P; Rousseau G; Charlotte F; Esselma G; Savier E; Thabut D; Rudler M; Eyraud D; Vezinet C; Siksik JM; Vaillant JC; Hannoun L; Poynard T; Ratziu V Clin Gastroenterol Hepatol; 2015 May; 13(5):992-9.e2. PubMed ID: 25459558 [TBL] [Abstract][Full Text] [Related]
16. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Ahn SY; Kim SB; Song IH Can J Gastroenterol Hepatol; 2020; 2020():4873875. PubMed ID: 32566546 [TBL] [Abstract][Full Text] [Related]
17. Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma. Kumar R; Goh BG; Kam JW; Chang PE; Tan CK Clin Mol Hepatol; 2020 Apr; 26(2):196-208. PubMed ID: 31914720 [TBL] [Abstract][Full Text] [Related]
18. Diabetes and racial/ethnic differences in hepatocellular carcinoma risk: the multiethnic cohort. Setiawan VW; Hernandez BY; Lu SC; Stram DO; Wilkens LR; Le Marchand L; Henderson BE J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25326644 [TBL] [Abstract][Full Text] [Related]
19. Asian perspective on NAFLD-associated HCC. Yip TC; Lee HW; Chan WK; Wong GL; Wong VW J Hepatol; 2022 Mar; 76(3):726-734. PubMed ID: 34619251 [TBL] [Abstract][Full Text] [Related]
20. Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective. Li JW; Goh BG; Chang PE; Tan CK World J Gastroenterol; 2017 Jun; 23(22):4054-4063. PubMed ID: 28652658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]